Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma

BACKGROUND: Liver hepatocellular carcinoma (LIHC) is the second leading cause of tumor-related death in the world. Carvacrol was also found to inhibit multiple cancer types. Here, we proposed that Carvacrol inhibited LIHC. METHODS: We used MTT assay to determine the inhibition of Carvacrol on LIHC c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xieling, Chen, Hongjian, Chen, Shi, Zhang, Suqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986433/
https://www.ncbi.nlm.nih.gov/pubmed/35401884
http://dx.doi.org/10.1155/2022/3736104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986433/
https://www.ncbi.nlm.nih.gov/pubmed/35401884
http://dx.doi.org/10.1155/2022/3736104

Ejemplares similares